1. Neuro/Emotional/ Behavioral Status
OASIS-C
Neuro/Emotional/
Behavioral Status
Contact: Cindy Skogen, RN (OEC)
, or
for questions.
Source: Center for Medicare and Medicaid Services
Neuro/Emotional/Behavioral Status

2. M1700 Cognitive Functioning
(M1700) Cognitive Functioning: Patient's current (day of assessment) level of alertness, orientation, comprehension, concentration, and immediate memory for simple commands.
⃞ 0 – Alert/oriented, able to focus and shift attention, comprehends and recalls task directions independently.
⃞ 1 – Requires prompting (cuing, repetition, reminders) only under stressful or unfamiliar conditions.
⃞ 2 – Requires assistance and some direction in specific situations (e.g., on all tasks involving shifting of attention), or consistently requires low stimulus environment due to distractibility.
⃞ 3 – Requires considerable assistance in routine situations. Is not alert and oriented or is unable to shift attention and recall directions more than half the time.
⃞ 4 – Totally dependent due to disturbances such as constant disorientation, coma, persistent vegetative state, or delirium.
This item is used in the calculation of quality measures.
Instructions to Class
Neuro/Emotional/Behavioral Status

3. M1700 Cognitive Functioning (cont.)
Identifies current level of cognitive functioning
Including alertness, orientation, comprehension, concentration, and immediate memory for simple commands
Consider the patient’s signs/symptoms of cognitive dysfunction at the time of the assessment and that have occurred over the past 24 hours
Consider amount of supervision and care required due to cognitive deficits
Neuro/Emotional/Behavioral Status

4. M1700 Cognitive Functioning (cont.)
Patients with dementia, delirium, development delay disorders, mental retardation, etc., will have various degrees of cognitive dysfunction
Consider the degree of impairment
Patients with neurological deficits related to stroke, mood/anxiety disorders or who receive opioid therapy may have cognitive deficits
Neuro/Emotional/Behavioral Status

5. M1710 When Confused
(M1710) When Confused (Reported or Observed Within the Last 14 Days):
⃞ 0 – Never
⃞ 1 – In new or complex situations only
⃞ 2 – On awakening or at night only
⃞ 3 – During the day and evening, but not constantly
⃞ 4 – Constantly
⃞ NA – Patient nonresponsive
This item is used in the calculation of quality measures.
Instructions to Class
Neuro/Emotional/Behavioral Status

6. M1710 When Confused (cont.)
Identifies the time of day or situations when the patient experienced confusion, if at all
Assess specifically for confusion in the past 14 days
May not relate directly to M1700, Cognitive Functioning, as it reports what’s true on the day of assessment
OAI note: Include info below on slide…
Note that in the past the clinician determined the timeframe, now it is specified as the past two weeks.
CMS Q & A October 2009
M1710, When Confused and M1720, When Anxious
Question 26: May the clinician use clinical judgment to determine if the confusion or anxiety is relevant to this home health episode or should they report all confusion during the past 14 days, (e.g., my patient was anxious 14 days ago and was started on an antianxiety
drug and has not experienced anxiety for the last 12 days)?
Answer 26: When completing M1710, When Confused and M1720, When Anxious, the clinician should report any episodes of confusion or anxiety that meet the descriptors contained in the item that occurred during the last 14 days, without regard to the cause or potential relevance of the confusion/anxiety to this episode of care.
Neuro/Emotional/Behavioral Status

7. M1710 When Confused (cont.)
Report any episode of confusion that occurred during the past 14 days, without regard to the cause or potential relevance of the confusion to this episode of care
This item may not relate directly to M1700, Cognitive Functioning
Assess specifically for confusion in past 14 days
Neuro/Emotional/Behavioral Status

8. M1710 When Confused (cont.)
If “occasionally” confused, identify the situation(s) in which confusion has occurred within the last 14 days, if at all
“Nonresponsive” means patient is unable to respond or responds in a way that you can’t make a clinical judgment about the patient’s level of orientation
Neuro/Emotional/Behavioral Status

9. M1720 When Anxious
(M1720) When Anxious (Reported or Observed Within the Last 14 Days):
⃞ 0 – None of the time
⃞ 1 – Less often than daily
⃞ 2 – Daily, but not constantly
⃞ 3 – All of the time
⃞ NA – Patient nonresponsive
Used in the calculation of quality measures. Emphasize we have already established how to determine the past 14 days and what nonresponsive means.
Instructions to Class
Neuro/Emotional/Behavioral Status

10. M1720 When Anxious (cont.)
Identifies frequency the patient has felt anxious within the past 14 days
Anxiety includes:
Worry that interferes with learning and normal activities or
Feelings of being overwhelmed and having difficulty coping or
Symptoms of anxiety disorders
Neuro/Emotional/Behavioral Status

11. M1730 Depression Screening
(M1730) Depression Screening: Has the patient been screened for depression, using a standardized depression screening tool?
⃞ 0 – No
⃞ 1 – Yes, patient was screened using the PHQ-2© scale. (Instructions for this two- question tool: Ask patient: “Over the last two weeks, how often have you been bothered by any of the following problems”?)
PHQ-2© Pfizer
Not at all 0 – 1 day
Several days
2 - 6 days
More than half of the days
7 – 11 days
Nearly every day
12 – 14 days
N/A
Unable to respond
a) Little interest or pleasure in doing things
⃞ 0
⃞ 1
⃞ 2
⃞ 3
⃞ na
b) Feeling down, depressed, or hopeless?
This item is used in the calculation of quality measures.
Instructions to Class
⃞ 2 – Yes, with a different standardized assessment, and the patient meets criteria for further evaluation for depression.
⃞ 3 – Yes, patient was screened with a different standardized assessment, and the patient does not meet criteria for further evaluation for depression.
Collect at SOC/ROC
Copyright© Pfizer Inc. All rights reserved. Reproduced with permission.
Neuro/Emotional/Behavioral Status

12. M1730 Depression Screening (cont.)
Yes, patient was screened using the PHQ-2© scale. (Instructions for this two- question tool: Ask patient: “Over the last two weeks, how often have you been bothered by any of the following problems”?)
PHQ-2© Pfizer
Not at all 0 – 1 day
Several days
2 - 6 days
More than half of the days
7 – 11 days
Nearly every day
12 – 14 days
N/A
Unable to respond
a) Little interest or pleasure in doing things
⃞ 0
⃞ 1
⃞ 2
⃞ 3
⃞ na
b) Feeling down, depressed, or hopeless?
N/A should not be used for unresponsive /cognitively impaired residents
Pt is source of answers-cannot ask family these questions.
Copyright© Pfizer Inc. All rights reserved. Reproduced with permission.
Neuro/Emotional/Behavioral Status

13. M1730 Depression Screening (cont.)
Has the assessing clinician screened the patient for depression within the allowed timeframe using a standardized depression screening tool?
CMS does not mandate that clinicians conduct depression screening for all patients, nor the use of the PHQ-2 or any other particular standardized tool
Item used for Process Measure – Best Practices
The best practices in this item are not necessarily required in the CoPs
OAI edit: Added that it’s the assessing clinician, not the HHA, who must assess for depression within the allowed timeframe for completing the assessment
Neuro/Emotional/Behavioral Status

14. M1730 Depression Screening (cont.)
Depressive feelings, symptoms and/or behaviors may be observed by the clinician or reported by the patient, family, or others
If a standardized depression screening tool is used, use the scoring parameters specified for the tool to identify if a patient meets criteria for further evaluation of depression
Select “0” if a standardized depression screening was not conducted
Neuro/Emotional/Behavioral Status

15. M1730 Depression Screening (cont.)
Select “1” if the PHQ-2 Pfizer is completed when responding to the question:
“Over the last two weeks, how often have you been bothered by any of the following problems?”
The results for row a & b are for agency use only and will not be encoded and transmitted with OASIS data
If pt scores at “3” or higher on the PHQ-2, further depression screening is indicated
-If pt scores at “3” or higher on the PHQ-2, further depression screening is incidated
Neuro/Emotional/Behavioral Status

16. M1730 Depression Screening (cont.)
PHQ-2
Total score = 3 or higher indicates need for further evaluation
Results for row a & b are for agency use only and not transmitted
The patient is the source
Not to be administered by asking caregiver the questions or based on clinical observation
If assessment revealed PHQ-2 appropriate for patient, but then clinician cannot elicit responses, select Response 1 with NA as answer
If PHQ-2 is not appropriate for patient due to their cognitive status or communication deficits, may choose a different tool
Select Response 2 or 3
If agency provides no appropriate tool, select Response 0 – No
OAI edit: Re-arranged the slides so this information was introduced when appropriate.
CMS Q & A April 2010
Question 18
No, it is not acceptable to use the PHQ-2 to screen for depression by asking the questions of a caregiver, or to respond to the two questions based on clinician observations. The PHQ-2 tool is a standardized, validated screening tool in which the patient is the source of report. The PHQ-2 instructions clearly define how the tool should be administered. The clinician is to ask the patient a specific question related to two problems. The information may also be self-reported, precluding the need for the interview.
When evaluating the patient, the clinician must first assess whether the PHQ-2 is the CMS OCCB Q&As – April 2010 ( Page 8 of 20 appropriate depression screening tool. If the PHQ-2 is appropriate (the patient appears to be cognitively and physically able to respond), then the instrument may be used. If, however, the clinician is then unable to elicit responses to either of the PHQ-2 questions from the patient during the assessment, the clinician can report in M1730 that the PHQ- 2 was administered (Response 1), and select N/A - unable to respond.
If the PHQ-2 is not appropriate due to limitations such as cognitive status or communication deficits, the clinician may choose to administer a different standardized depression screening tool with instructions that may allow for information to be gathered by observation and caregiver interview as well as self-report. In this case, the clinician would select Response 2 or 3 for M1730, depending on the outcome of the assessment.
If the clinician chooses not to assess the patient (because there is no appropriate depression screening tool available or for any other reason), Response 0, “No” should be selected. Note that patients who have been assessed as “unresponsive”, based on M1710, When Confused and/or M1720, When Anxious, will not be included in the process measure for depression screening.
Neuro/Emotional/Behavioral Status

17. M1730 Depression Screening (cont.)
Select “2” if the patient is screened with a different standardized assessment
And the tool indicated the need for further evaluation
Select “3” if the patient is screened with a different standardized assessment
But the tool indicates no need for further evaluation
Neuro/Emotional/Behavioral Status

18. M1740 Cognitive, Behavioral, & Psychiatric Symptoms
(M1740) Cognitive, behavioral, and psychiatric symptoms that are demonstrated at least once a week (Reported or Observed): (Mark all that apply.)
⃞ 1 – Memory deficit: failure to recognize familiar persons/places, inability to recall events of past 24 hours, significant memory loss so that supervision is required
⃞ 2 – Impaired decision-making: failure to perform usual ADLs or IADLs, in­ability to appropriately stop activities, jeopardizes safety through actions
⃞ 3 – Verbal disruption: yelling, threatening, excessive profanity, sexual references, etc.
⃞ 4 – Physical aggression: aggressive or combative to self and others (e.g., hits self, throws objects, punches, dangerous maneuvers with wheelchair or other objects)
⃞ 5 – Disruptive, infantile, or socially inappropriate behavior (excludes verbal actions)
⃞ 6 – Delusional, hallucinatory, or paranoid behavior
⃞ 7 – None of the above behaviors demonstrated
This item is used for quality measures.
Instructions to Class
Neuro/Emotional/Behavioral Status

19. M1740 Cognitive, Behavioral, & Psychiatric Symptoms (cont.)
(M1740) Cognitive, behavioral, and psychiatric symptoms that are demonstrated at least once a week (Reported or Observed): (Mark all that apply.)
⃞ 1 – Memory deficit: failure to recognize familiar persons/places, inability to recall events of past 24 hours, significant memory loss so that supervision is required
⃞ 2 – Impaired decision-making: failure to perform usual ADLs or IADLs, in­ability to appropriately stop activities, jeopardizes safety through actions
Instructional Guidance
Instructions to Class
Neuro/Emotional/Behavioral Status

20. M1740 Cognitive, Behavioral, & Psychiatric Symptoms (cont.)
⃞ 3 – Verbal disruption: yelling, threatening, excessive profanity, sexual references, etc.
⃞ 4 – Physical aggression: aggressive or combative to self and others (e.g., hits self, throws objects, punches, dangerous maneuvers with wheelchair or other objects)
⃞ 5 – Disruptive, infantile, or socially inappropriate behavior (excludes verbal actions)
⃞ 6 – Delusional, hallucinatory, or paranoid behavior
⃞ 7 – None of the above behaviors demonstrated
Instructional Guidance
Instructions to Class
Neuro/Emotional/Behavioral Status

21. M1740 Cognitive, Behavioral, & Psychiatric Symptoms (cont.)
Identifies specific behaviors associated with significant neurological, developmental, behavioral or psychiatric disorders
Demonstrated once a week
Behaviors may be observed by the clinician or reported by the patient, family, or others
Neuro/Emotional/Behavioral Status

22. M1740 Cognitive, Behavioral, & Psychiatric Symptoms (cont.)
Include behaviors severe enough to:
Make the patient unsafe to self or others or
Cause considerable stress to caregivers or
Require supervision or intervention
If “7” is selected, none of the other responses should be selected
Neuro/Emotional/Behavioral Status

23. M1745 Frequency of Disruptive Behavior Symptoms
(M1745) Frequency of Disruptive Behavior Symptoms (Reported or Observed) Any physical, verbal, or other disruptive/dangerous symptoms that are injurious to self or others or jeopardize personal safety.
⃞ 0 – Never
⃞ 1 – Less than once a month
⃞ 2 – Once a month
⃞ 3 – Several times each month
⃞ 4 – Several times a week
⃞ 5 – At least daily
This item is used for quality measures.
Instructions to Class
Neuro/Emotional/Behavioral Status

24. M1745 Frequency of Disruptive Behavior Symptoms (cont.)
Identifies frequency of any behaviors that are disruptive or dangerous to pt. or caregivers
Are there any problematic behaviors which jeopardize or could jeopardize the safety and well-being of the patient or caregiver?
Not just the behaviors listed in M1740 – Cognitive, behavioral, and psychiatric symptoms
How frequently do these behaviors occur?
M1740 contains a list of specific behaviors associated with significant neurological, developmental, behavioral or psychiatric disorders and asks if they are demonstrated by the patient at least once a week. M1745 is not reporting on a specific list of behaviors, but rather any behaviors that are disruptive or dangerous to the patient or the caregivers.
Neuro/Emotional/Behavioral Status

25. M1745 Frequency of Disruptive Behavior Symptoms (cont.)
Include behaviors considered symptomatic of neurological, cognitive, behavioral, developmental, or psychiatric disorders
Use clinical judgment to determine if degree of the behavior is disruptive or dangerous to the patient or caregiver
Behaviors can be observed by the clinician or reported by the patient, family, or others
CMS Q & A July 2010
Question 12: When completing M Frequency of Disruptive Behavior Symptoms, do we have to take into consideration if the patient has a full-time caregiver to watch over her, or do we address it without including the caregiver's presence?
Answer 12: The environment in which the patient lives and the skills of the caregiver may impact the scoring of M Cognitive, behavioral, and psychiatric symptoms, and M Frequency of Disruptive Behavior Symptoms. For example, if a patient has dementia, they may exhibit a number of behaviors listed in M1740, but may not be reported in the OASIS item if they live in a setting specifically designed to care for patients with dementia. The same would be true for M1745. Look to the descriptors for the behaviors that are reportable for both M1740 and M1745 to determine if the behavior would be reportable.
Neuro/Emotional/Behavioral Status

26. M1745 Frequency of Disruptive Behavior Symptoms (cont.)
Examples of disruptive/dangerous behaviors include:
Sleeplessness, “sun-downing”
Agitation, wandering
Aggression, combativeness
Getting lost in familiar places, etc.
Neuro/Emotional/Behavioral Status

27. M1750 Psychiatric Nursing
(M1750) Is this patient receiving Psychiatric Nursing Services at home provided by a qualified psychiatric nurse?
⃞ 0 – No
⃞ 1 – Yes
Instructional Guidance
Instructions to Class
Neuro/Emotional/Behavioral Status

28. M1750 Psychiatric Nursing (cont.)
Identifies whether patient is receiving psychiatric nursing services at home as provided by a qualified psychiatric nurse
“Psychiatric nursing services” address mental/emotional needs
A “qualified psychiatric nurse” is so qualified through educational preparation, certification, or experience
Providers should direct questions related to the qualifications of the psychiatric nurse to your intermediary.
Neuro/Emotional/Behavioral Status

29. Questions??? E-mail: health.oasis@state.mn.us
Cindy Skogen, RN;
Oasis Education Coordinator